Juno Therapeutics

New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths
Xtalks
Wed, 09/20/17 - 10:41 am
CAR-T
Juno Therapeutics
Kite Pharma
Cellectis
[video+transcript]Are These Healthcare Stocks Top Takeover Targets?
Motley Fool
Thu, 09/7/17 - 07:40 pm
M&A
Juno Therapeutics
Medtronic
Mazor Robotics
devices
3 Biotech Stocks That Skyrocketed This Past Week
Motley Fool
Mon, 09/4/17 - 10:07 am
Abeona Therapeutics
EB-101
Sangamo BioSciences
SB-525
Juno Therapeutics
CAR-T
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Mon, 08/28/17 - 10:26 pm
Bluebird Bio
Juno Therapeutics
Gilead Sciences
Kite Pharma
CAR-T
M&A
Juno Therapeutics' Cash Position and Potential Cash Cow JCAR017 Are Still What's Important
Motley Fool
Fri, 08/4/17 - 11:37 am
Juno Therapeutics
JCAR017
earnings
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Motley Fool
Sun, 07/9/17 - 11:41 am
Celgene
Juno Therapeutics
Acceleron
Bluebird Bio
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Investors Business Daily
Sun, 07/2/17 - 10:07 am
Celgene
Bluebird Bio
Kite Pharma
Juno Therapeutics
CAR-T
immuno-oncology
bb2121
With Kite’s PDUFA date looming, federal court tosses Juno’s CAR-T patent challenge — for now
Endpoints
Wed, 06/14/17 - 11:43 am
Kite Pharma
PDUFA
CAR-T
patents
Juno Therapeutics
KTE-C19
ASCO17: Juno marks progress with second-gen CAR-T
BioPharma Dive
Tue, 06/6/17 - 12:16 pm
ASCO 2017
Juno Therapeutics
CAR-T
JCAR017
non-Hodgkin's lymphoma
JCAR015
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
ASCO 2017
Merck
AbbVie
Eli Lilly
Bluebird Bio
Epizyme
Juno Therapeutics
Kite
Merus
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
Juno Therapeutics Q1 Revenue Improves Thanks to Celgene Collaboration
Motley Fool
Mon, 05/8/17 - 09:56 pm
Juno Therapeutics
earnings
Celgene
One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm
Endpoints
Mon, 05/8/17 - 11:33 am
Kite Pharma
CAR-T
cerebral edema
KTE-C19
Juno Therapeutics
Why Juno Therapeutics Stock Slumped in March
Motley Fool
Sun, 04/9/17 - 12:17 pm
Juno Therapeutics
JCAR015
CAR-T
The ​ABCs of Juno's failed flagship drug trial
Bizjournals.com
Sat, 03/11/17 - 11:52 am
Juno Therapeutics
clinical trials
CAR-T
JCAR015
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Mon, 03/6/17 - 09:40 am
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
Juno ends flagship drug trial after deaths and FDA suspensions
Bizjournals.com
Wed, 03/1/17 - 08:59 pm
Juno Therapeutics
clinical trials
FDA
JCAR015
CAR-T
acute lymphoblastic leukemia
The Most Important Keys To Celgene's Pipeline
Seeking Alpha
Sat, 01/21/17 - 11:32 am
Celgene
Revlimid
Acceleron
Juno Therapeutics
Agios
Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent
Yahoo
Mon, 12/19/16 - 11:41 am
Juno Therapeutics
Kite Pharma
CAR-T
patents

Pages